Exact Mass: 993.4502141999999

Exact Mass Matches: 993.4502141999999

Found 7 metabolites which its exact mass value is equals to given mass value 993.4502141999999, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Atosiban

(Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin acetate salt

C43H67N11O12S2 (993.4411862000001)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C98292 - Oxytocin Antagonist D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents G - Genito urinary system and sex hormones Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research[1].

   

Atosiban

5-amino-2-({1-[13-(butan-2-yl)-7-(carbamoylmethyl)-16-[(4-ethoxyphenyl)methyl]-10-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl]pyrrolidin-2-yl}formamido)-N-(carbamoylmethyl)pentanamide

C43H67N11O12S2 (993.4411862000001)


Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research[1].

   

GlcNAc-MurNAc-Ala-iGln-A2pm(-Gly)-Ala

GlcNAc-MurNAc-Ala-iGln-A2pm(-Gly)-Ala

C40H67N9O20 (993.4502141999999)


   

(Deamino-Cys1,D-Tyr(Et)2,Thr4,Orn8)-Oxytocin acetate salt

1-({(4r,7s,13s,16r)-7-(2-Amino-2-oxoethyl)-13-[(2s)-butan-2-yl]-16-(4-ethoxybenzyl)-10-[(1r)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-l-prolyl-l-ornithylglycinamide

C43H67N11O12S2 (993.4411862000001)


Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research[1].

   

2-[(2-amino-1-hydroxyethylidene)amino]-6-[(1-carboxyethyl)-c-hydroxycarbonimidoyl]-6-[(4-{[2-({3-[3-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-6-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-4-yl]-1-hydroxy-2-methylpropylidene}amino)-1-hydroxypropylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene)amino]hexanoic acid

2-[(2-amino-1-hydroxyethylidene)amino]-6-[(1-carboxyethyl)-c-hydroxycarbonimidoyl]-6-[(4-{[2-({3-[3-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-6-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-4-yl]-1-hydroxy-2-methylpropylidene}amino)-1-hydroxypropylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene)amino]hexanoic acid

C40H67N9O20 (993.4502141999999)


   

(2r,6s)-2-[(2-amino-1-hydroxyethylidene)amino]-6-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-6-{[(4s)-4-{[(2s)-2-{[(2s)-3-[(2r,3s,4r,5r,6r)-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-4-yl]-1-hydroxy-2-methylpropylidene]amino}-1-hydroxypropylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene]amino}hexanoic acid

(2r,6s)-2-[(2-amino-1-hydroxyethylidene)amino]-6-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-6-{[(4s)-4-{[(2s)-2-{[(2s)-3-[(2r,3s,4r,5r,6r)-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-4-yl]-1-hydroxy-2-methylpropylidene]amino}-1-hydroxypropylidene]amino}-1-hydroxy-4-(c-hydroxycarbonimidoyl)butylidene]amino}hexanoic acid

C40H67N9O20 (993.4502141999999)


   

5-amino-2-{[(1-{16-[(4-ethoxyphenyl)methyl]-6,9,12,15,18-pentahydroxy-7-(c-hydroxycarbonimidoylmethyl)-10-(1-hydroxyethyl)-13-(sec-butyl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-n-(c-hydroxycarbonimidoylmethyl)pentanimidic acid

5-amino-2-{[(1-{16-[(4-ethoxyphenyl)methyl]-6,9,12,15,18-pentahydroxy-7-(c-hydroxycarbonimidoylmethyl)-10-(1-hydroxyethyl)-13-(sec-butyl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-n-(c-hydroxycarbonimidoylmethyl)pentanimidic acid

C43H67N11O12S2 (993.4411862000001)